Clinical trial
Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV
NCT00090779 · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Other · Terminated
Key facts
| NCT number | NCT00090779 |
|---|---|
| Title | Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV |
| Official title | The SETPOINT Study - A Randomized Study of the Effect of Immediate Treatment With Potent Antiretroviral Therapy Versus Observation With Treatment as Indicated in Newly Infected HIV-1 Infected Subjects: Does Early Therapy After the Virologic Setpoint? |
| Lead sponsor | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH Adult AIDS Clinical Trials Group |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Emtricitabine/ tenofovir disoproxil fumarate, Lopinavir/Ritonavir |
| Enrollment | 130 |
| Start date | Jan 1, 2005 |
| Primary completion | Jul 1, 2009 |
| Completion | May 1, 2011 |
| First posted | Sep 6, 2004 |
| Last update posted | Oct 11, 2018 |
| Countries | Peru, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: